RPRX Royalty Pharma plc
Nasdaq · SEC CIK 1802768 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $92.35M 40 sales by 5 insiders
- Filings on record
- 237 since 2021-07-08, latest 2026-09-24 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Coyne Terrance P. | EVP, CFO | — | $38.96M |
| Hite Christopher | EVP, Vice COB | — | $27.36M |
| Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| Urist Marshall | EVP, Research, Investments | — | $12.07M |
| Norden Gregory | Dir | — | $161.4K |
| Engelbert Catherine M. | Dir | — | — |
| Ho Carole | Dir | — | — |
| Coric Vlad | Dir | — | — |
| Bassler Bonnie L | Dir | — | — |
| Legorreta Pablo G. | CEO, COB, Dir | — | — |
Transactions 244
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-24 | 2022-06-24 | RPRX | Norden Gregory | Dir | A - Grant | $0.00 | +6,328 | 56.7K | +13% | $0 | |
| 2022-06-24 | 2022-06-24 | RPRX | HODGSON DAVID C | Dir | A - Grant | $0.00 | +6,328 | 6,328 | New | $0 | |
| I | 2022-06-10 | 2022-06-08 | RPRX | Reddoch James F. | EVP, CSO | S - Sale | $41.56 | -100.0K | 920.8K | -10% | -$4.16M |
| MI | 2022-05-31 | 2022-05-26+ | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $40.29 | -100.0K | 430.0K | -19% | -$4.03M |
| I | 2022-05-31 | 2022-05-27 | RPRX | Reddoch James F. | EVP, CSO | S - Sale | $41.08 | -75.0K | 1.02M | -7% | -$3.08M |
| I | 2022-05-25 | 2022-05-23 | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $40.27 | -100.0K | 530.0K | -16% | -$4.03M |
| M | 2022-05-23 | 2022-05-19+ | RPRX | RIGGS RORY B | Dir | S - Sale | $39.42 | -150.0K | 451.7K | -25% | -$5.91M |
| I | 2022-05-23 | 2022-05-19 | RPRX | Reddoch James F. | EVP, CSO | S - Sale | $40.44 | -75.0K | 1.10M | -6% | -$3.03M |
| 2022-05-16 | 2022-05-16 | RPRX | Urist Marshall | EVP, Research, Investments | S - Sale | $39.85 | -23.3K | 46.7K | -33% | -$929.8K | |
| D | 2022-05-11 | 2022-05-11 | RPRX | Urist Marshall | EVP, Research, Investments | C - Cnv Deriv | $0.00 | +70.0K | 70.0K | New | $0 |
| D | 2022-04-15 | 2022-04-14 | RPRX | Legorreta Pablo G. | CEO, COB, Dir, 10% | J - Other | $0.00 | -350.0K | 63.8K | -85% | $0 |
| DI | 2022-04-15 | 2022-04-14 | RPRX | Legorreta Pablo G. | CEO, COB, Dir, 10% | J - Other | $0.00 | -462.0K | 0 | -100% | $0 |
| DMI | 2022-04-15 | 2020-06-16+ | RPRX | Legorreta Pablo G. | CEO, COB, Dir, 10% | C - Cnv Deriv | $0.00 | +922.2K | 493.8K | New | $0 |
| 2022-04-01 | 2022-03-31 | RPRX | Bassler Bonnie L | Dir | A - Grant | $38.87 | +964 | 24.7K | +4% | +$37.5K | |
| 2022-04-01 | 2022-03-31 | RPRX | Fernandez Henry A | Dir | A - Grant | $38.87 | +964 | 18.9K | +5% | +$37.5K | |
| 2022-03-30 | 2022-03-29 | RPRX | RIGGS RORY B | Dir | S - Sale | $38.59 | -60.0K | 601.7K | -9% | -$2.32M | |
| M | 2022-03-21 | 2022-03-17 | RPRX | RIGGS RORY B | Dir | J - Other | — | +69.0K | 661.7K | +12% | — |
| MI | 2022-03-21 | 2022-03-17 | RPRX | RIGGS RORY B | Dir | J - Other | — | -1.84M | 141.4K | -93% | — |
| MI | 2022-03-21 | 2022-03-18+ | RPRX | RIGGS RORY B | Dir | S - Sale | $39.43 | -169.1K | 0 | -100% | -$6.67M |
| I | 2022-02-25 | 2022-02-24 | RPRX | Fernandez Henry A | Dir | P - Purchase | $37.49 | +32.5K | 58.2K | +126% | +$1.22M |
| 2022-01-03 | 2021-12-31 | RPRX | Bassler Bonnie L | Dir | A - Grant | $39.11 | +958 | 23.7K | +4% | +$37.5K | |
| 2022-01-03 | 2021-12-31 | RPRX | Fernandez Henry A | Dir | A - Grant | $39.11 | +958 | 17.9K | +6% | +$37.5K | |
| M | 2021-12-30 | 2021-12-28 | RPRX | RIGGS RORY B | Dir | J - Other | — | +45.4K | 667.7K | +7% | — |
| MI | 2021-12-30 | 2021-12-28 | RPRX | RIGGS RORY B | Dir | J - Other | — | -1.27M | 708.2K | -64% | — |
| 2021-12-30 | 2021-12-29 | RPRX | RIGGS RORY B | Dir | S - Sale | $40.00 | -75.0K | 592.7K | -11% | -$3.00M | |
| MI | 2021-12-30 | 2021-12-28 | RPRX | RIGGS RORY B | Dir | S - Sale | $40.21 | -109.4K | 673.1K | -14% | -$4.40M |
| DMI | 2021-11-18 | 2021-11-16+ | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.39 | -250.0K | 495.9K | -34% | -$10.60M |
| M | 2021-11-18 | 2021-11-16 | RPRX | RIGGS RORY B | Dir | J - Other | — | +66.0K | 636.1K | +12% | — |
| M | 2021-11-18 | 2021-11-16+ | RPRX | RIGGS RORY B | Dir | S - Sale | $42.33 | -75.0K | 622.4K | -11% | -$3.17M |
| MI | 2021-11-18 | 2021-11-16 | RPRX | RIGGS RORY B | Dir | J - Other | — | -1.86M | 1.15M | -62% | — |
| MI | 2021-11-18 | 2021-11-17 | RPRX | RIGGS RORY B | Dir | S - Sale | $42.35 | -139.4K | 1.12M | -11% | -$5.90M |
| 2021-09-30 | 2021-09-30 | RPRX | Bassler Bonnie L | Dir | A - Grant | $37.80 | +992 | 22.8K | +5% | +$37.5K | |
| DM | 2021-09-30 | 2021-09-29 | RPRX | RIGGS RORY B | Dir | J - Other | — | +16.3K | 631.4K | +3% | — |
| DMI | 2021-09-30 | 2021-09-29 | RPRX | RIGGS RORY B | Dir | J - Other | — | -936.4K | 789.5K | -54% | — |
| DMI | 2021-09-30 | 2021-09-29 | RPRX | RIGGS RORY B | Dir | S - Sale | $36.35 | -63.8K | 899.3K | -7% | -$2.32M |
| DM | 2021-09-30 | 2021-09-28+ | RPRX | RIGGS RORY B | Dir | S - Sale | $36.65 | -64.6K | 615.1K | -10% | -$2.37M |
| 2021-09-30 | 2021-09-30 | RPRX | Fernandez Henry A | Dir | A - Grant | $37.80 | +992 | 17.0K | +6% | +$37.5K | |
| MI | 2021-07-27 | 2021-07-26 | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $39.78 | -13.4K | 595.9K | -2% | -$531.5K |
| I | 2021-07-27 | 2021-07-26 | RPRX | Reddoch James F. | EVP, Research, Investments | S - Sale | $39.78 | -8,949 | 1.17M | -0.8% | -$356.0K |
| I | 2021-07-27 | 2021-07-26 | RPRX | Reddoch James F. | EVP, Research, Investments | S - Sale | $39.78 | -8,949 | 1.17M | -0.8% | -$356.0K |
| MI | 2021-07-14 | 2021-07-12+ | RPRX | Reddoch James F. | EVP, Research, Investments | S - Sale | $42.01 | -17.9K | 1.18M | -1% | -$753.4K |
| MI | 2021-07-14 | 2021-07-12+ | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.01 | -23.1K | 600.8K | -4% | -$972.5K |
| MI | 2021-07-08 | 2021-07-06+ | RPRX | Lloyd George W. | EVP, GC, Investments | S - Sale | $42.20 | -88.5K | 849.7K | -9% | -$3.73M |
| MI | 2021-07-08 | 2021-07-06+ | RPRX | Reddoch James F. | EVP, Research, Investments | S - Sale | $42.19 | -73.1K | 1.24M | -6% | -$3.09M |
Purchase Sale Sale after option exercise All abbreviations